CANF
Can-fite Biopharma·AMEX
--
--(--)
--
--(--)
3.79 / 10
Netural
Capital flows are largely constructive (score 7.57/10), with block, medium, and extra-large trends positive, though Large flow is negative. Analyst coverage is exclusively Strong Buy but historically unreliable (0.0% win rate). The synergy of positive fund flow and mixed analyst conviction provides only modest support against weak fundamentals and technicals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-17
InstitutionD. Boral Capital
Times predicted11
Historical Win Rate0.0%
What is the market sentiment for CANF?
- CANF holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.79/10 (Netural).
